Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists by Yamazaki, T, Hannani, D, Poirier-Colame, V, Ladoire, S, Locher, C, Sistigu, A, Prada, N, Adjemian, S, Catani, J PP, Freudenberg, M, Galanos, C, André, F, Kroemer, G, Zitvogel, L

Get full text

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells by Derangère, V, Chevriaux, A, Courtaut, F, Bruchard, M, Berger, H, Chalmin, F, Causse, S Z, Limagne, E, Végran, F, Ladoire, S, Simon, B, Boireau, W, Hichami, A, Apetoh, L, Mignot, G, Ghiringhelli, F, Rébé, C

Get full text

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study by Mirjolet, C., Charon-Barra, C., Ladoire, S., Arbez-Gindre, F., Bertaut, A., Ghiringhelli, F., Leroux, A., Peiffert, D., Borg, C., Bosset, J. F., Créhange, G.

Get full text

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer by Poumeaud, F., Morisseau, M., Cabel, L., Gonçalves, A., Rivier, C., Trédan, O., Volant, E., Frenel, J.-S., Ladoire, S., Jacot, W., Jamelot, M., Foka Tichoue, H., Patsouris, A., Teixeira, L., Bidard, F.-C., Loirat, D., Brunet, M., Levy, C., Bailleux, C., Cabarrou, B., Deleuze, A., Uwer, L., Deluche, E., Grellety, T., Franchet, C., Fiteni, F., Bischoff, H., Vion, R., Pagliuca, M., Verret, B., Bécourt, S., Reverdy, T., de Nonneville, A., Dalenc, F.

Get full text

T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival by Ladoire, S, Arnould, L, Mignot, G, Apetoh, L, Rébé, C, Martin, F, Fumoleau, P, Coudert, B, Ghiringhelli, F

Get full text

Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer by Guiu, S, Gauthier, M, Coudert, B, Bonnetain, F, Favier, L, Ladoire, S, Tixier, H, Guiu, B, Penault-Llorca, F, Ettore, F, Fumoleau, P, Arnould, L

Get full text

2009 Tumoral lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer as a prognostic factor for survival: The LYMPHOREC study by Mirjolet, C, Charon-barra, C, Arbez-gindre, F, Gauthier, M, Maingon, P, Barthod, Z, Leroux, A, Merlin, J.L, Peiffert, D, Dalban, C, Ladoire, S, Bosset, J.F, Crehange, G

Get full text

2607 Predicting venous thromboembolism (VTE) in metastatic urothelial tract tumors (UTT) by Ramos, J, Casey, M, Bamias, A, De Giorgi, U, Bellmunt, J, Harshman, L, Ladoire, S, Wong, Y.N, Alva, A, Necchi, A, Recine, F, Vaishampayan, U, Niegisch, G, Pal, S, Crabb, S, Golshayan, A, Srinivas, S, Rosenberg, J, Galsky, M, Yu, E

Get full text

2619 Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC) by Harshman, L, Werner, L, Wong, Y.N, Yu, E, Alva, A, Crabb, S, Powles, T, Rosenberg, J, Baniel, J, Vaishampayan, U, Berthold, D, Ladoire, S, Hussain, S, Milowsky, M, Agarwal, N, Necchi, A, Pal, S, Recine, F, Bellmunt, J, Galsky, M

Get full text

Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge? by Pignot, G., Thiery-Vuillemin, A., Walz, J., Lang, H., Werle, P., Balssa, L., Geoffrois, L., Leblanc, L., Albigès, L., Di Nunno, V., Bensalah, K., Ladoire, S., Gravis, G., Barthélémy, P.

Get full text

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 by Vacchelli, Erika, Ma, Yuting, Baracco, Elisa E., Sistigu, Antonella, Enot, David P., Pietrocola, Federico, Yang, Heng, Adjemian, Sandy, Chaba, Kariman, Semeraro, Michaela, Signore, Michele, De Ninno, Adele, Lucarini, Valeria, Peschiaroli, Francesca, Businaro, Luca, Gerardino, Annamaria, Manic, Gwenola, Ulas, Thomas, Günther, Patrick, Schultze, Joachim L., Kepp, Oliver, Stoll, Gautier, Lefebvre, Céline, Mulot, Claire, Castoldi, Francesca, Rusakiewicz, Sylvie, Ladoire, Sylvain, Apetoh, Lionel, Pedro, José Manuel Bravo-San, Lucattelli, Monica, Delarasse, Cécile, Boige, Valérie, Ducreux, Michel, Delaloge, Suzette, Borg, Christophe, André, Fabrice, Schiavoni, Giovanna, Vitale, Ilio, Laurent-Puig, Pierre, Mattei, Fabrizio, Zitvogel, Laurence, Kroemer, Guido

Get full text

375. Impact of Hyperthermia and Pressure on the Penetration of Oxaliplatin During Intra-peritoneal Chemotherapy by Facy, O, Poussier, M, Magnin, G, Ghiringhelli, F, Ladoire, S, Chauffert, B, Rat, P, Deballon, P. Ortega

Get full text

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression by Chalmin, Fanny, Mignot, Grégoire, Bruchard, Mélanie, Chevriaux, Angélique, Végran, Frédérique, Hichami, Aziz, Ladoire, Sylvain, Derangère, Valentin, Vincent, Julie, Masson, David, Robson, Simon C., Eberl, Gerard, Pallandre, Jean René, Borg, Christophe, Ryffel, Bernhard, Apetoh, Lionel, Rébé, Cédric, Ghiringhelli, Francois

Get full text

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells by Chalmin, Fanny, Ladoire, Sylvain, Mignot, Grégoire, Vincent, Julie, Bruchard, Mélanie, Remy-Martin, Jean-Paul, Boireau, Wilfrid, Rouleau, Alain, Simon, Benoit, Lanneau, David, De Thonel, Aurélie, Multhoff, Gabriele, Hamman, Arlette, Martin, François, Chauffert, Bruno, Solary, Eric, Zitvogel, Laurence, Garrido, Carmen, Ryffel, Bernhard, Borg, Christophe, Apetoh, Lionel, Rébé, Cédric, Ghiringhelli, François

Get full text

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer by Ladoire, Sylvain, Enot, David, Senovilla, Laura, Ghiringhelli, François, Poirier-Colame, Vichnou, Chaba, Kariman, Semeraro, Michaela, Chaix, Marie, Penault-Llorca, Frédérique, Arnould, Laurent, Poillot, Marie Laure, Arveux, Patrick, Delaloge, Suzette, Andre, Fabrice, Zitvogel, Laurence, Kroemer, Guido

Get full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial by Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark

Get full text

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer by Galsky, Matthew D., Pal, Sumanta K., Chowdhury, Simon, Harshman, Lauren C., Crabb, Simon J., Wong, Yu‐Ning, Yu, Evan Y., Powles, Thomas, Moshier, Erin L., Ladoire, Sylvain, Hussain, Syed A., Agarwal, Neeraj, Vaishampayan, Ulka N., Recine, Federica, Berthold, Dominik, Necchi, Andrea, Theodore, Christine, Milowsky, Matthew I., Bellmunt, Joaquim, Rosenberg, Jonathan E.

Get full text

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... by Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Dalenc, Florence, Bachelot, Thomas, Pierga, Jean-Yves, de la Motte Rouge, Thibault, Sabatier, Renaud, Dubot, Coraline, Ferrero, Jean Marc, Ladoire, Sylvain, Levy, Christelle, Mouret-Reynier, Marie-Ange, Lortholary, Alain, Grenier, Julien, Chakiba, Camille, Stefani, Laetitia, Plaza, Jérôme Edouard, Clatot, Florian, Teixeira, Luis, D'Hondt, Véronique, Vegas, Hélène, Derbel, Olfa, Garnier-Tixidre, Claire, Canon, Jean-Luc, Pistilli, Barbara, André, Fabrice, Bièche, Ivan, Callens, Céline, Lemonnier, Jérôme, Delaloge, Suzette, PISTILLI, Barbara, DALENC, Florence, BACHELOT, Thomas, SABATIER, Renaud, DUBOT, Coraline, FRENEL, Jean-Sébastien, FERRERO, Jean-Marc, LADOIRE, Sylvain, LEVY, Christelle, MOURET-REYNIER, Marie-Ange, HARDY-BESSARD, Anne-Claire, LORTHOLARY, Alain, GRENIER, Julien, CHAKIBA, Camille, STEFANI, Laetitia, SOULIE, Patrick, PLAZA, Jérôme Edouard, CLATOT, Florian, TEIXEIRA, Luis, D'HONDT, Véronique, VEGAS, Hélène, DERBEL, Olfa, GARNIER TIXIDRE, Claire, CHENEAU, Caroline, PAITEL, Jean-François, BERNARD-MARTY, Chantal, SPAETH, Dominique, MOULLET, Isabelle, DEIANA, Laura, GREILSAMER, Charlotte, VENAT-BOUVET, Laurence, DELECROIX, Valérie, MELIS, Adrien, ORFEUVRE, Hubert, NGUYEN, Suzanne, LEGOUFFE, Eric, ZANNETTI, Alain, LE SCODAN, Romuald, DOHOLLOU, Nadine, DALIVOUST, Philippe, ARSENE, Olivier, MARQUES, Nathalie, PETIT, Thierry, MOLLON, Delphine, DAUBA, Jérôme, BONNIN, Nathalie, GARDNER, Miriam, MARTI, Adina, LEVACHE, Charles-Briac, LACHAIER, Emma, ACHILLE, Mihaela, VALMAR, Christophe, BOUAITA, Ryan, MEDIONI, Jacques, FOA, Cyril, DEL PIANO, Francesco, GOZY, Michel, ESCANDE, Anne, LEDUC, Nicolas, LUCAS, Brigitte, AMMARGUELLAT, Hanifa, NAJEM, Abeer, TROUBOUL, Fanny, DESCLOS, Hervé, MAYEUR, Didier, LORCHEL, Fabrice, BOUDRANT, Axelle, GISSEROT, Olivier, ALLEAUME, Corinne, DE GRAMONT, Aimery

Get full text

A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Pa... by Colomba, Emeline, Jonas, Sarah Flora, Eymard, Jean-Christophe, Delva, Rémi, Brachet, Pierre Emmanuel, Neuzillet, Yann, Penel, Nicolas, Roubaud, Guilhem, Bompas, Emmanuelle, Mahammedi, Hakim, Longo, Raffaelle, Helissey, Carole, Barthélemy, Philippe, Borchiellini, Delphine, Hasbini, Ali, Priou, Franck, Saldana, Carolina, Voog, Eric, Narcisso, Bérangère, Ladoire, Sylvain, Berdah, Jean-François, Aisenfarb, Jean-Baptiste, Foulon, Stéphanie, Fizazi, Karim

Get full text

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints by Hudry, Delphine, Le Guellec, Solenn, Meignan, Samuel, Bécourt, Stéphanie, Pasquesoone, Camille, El Hajj, Houssein, Martínez-Gómez, Carlos, Leblanc, Éric, Narducci, Fabrice, Ladoire, Sylvain

Get full text